Video
Experts evaluate outcomes for men with low-grade prostate cancer undergoing RP
Author(s):
"[Low-grade prostate cancer] is a really interesting field right now," says Kevin Shee, MD, PhD.
Video Player is loading.
In this interview, Kevin Shee, MD, PhD, discusses the background key findings of the Journal of Urology study Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. Shee is a urology resident at the University of California, San Francisco.
Related Videos
Jason Scovell, MD, on clinical utility of IsoPSA across racial groups
Jim Hu, MD, on urinary continence recovery across RARP techniques
Interpreting PSA Trends in Patients Receiving Darolutamide Plus ADT With mHSPC
Ultra-Low PSA Threshold vs Traditional Thresholds In Clinical Practice
Special Report: Tips for PCPs on evaluating prostate cancer risk
Special Report: Tailoring prostate cancer care for older adults
Special Report: New strategies emerge for metastatic prostate cancer
Special Report: Biden’s prostate cancer diagnosis renews focus on screening guidelines
De novo metastatic prostate cancer: Understanding Biden’s prognosis and treatment options
Geoffrey Sonn, MD, on an AI risk mapping tool to predict seminal vesicle invasion
Related Content
